Kahan A - Search Results

1

High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.

Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D. Lemarechal H, et al. Among authors: kahan a. Clin Chim Acta. 2006 May;367(1-2):156-61. doi: 10.1016/j.cca.2005.12.006. Epub 2006 Feb 3. Clin Chim Acta. 2006. PMID: 16458876

2

Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis.

Allanore Y, Borderie D, Lemaréchal H, Ekindjian OG, Kahan A. Allanore Y, et al. Among authors: kahan a. Am J Med. 2004 May 1;116(9):595-600. doi: 10.1016/j.amjmed.2003.11.022. Am J Med. 2004. PMID: 15093755 Clinical Trial.

3

Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients.

Allanore Y, Borderie D, Lemaréchal H, Ekindjian OG, Kahan A. Allanore Y, et al. Among authors: kahan a. Clin Chim Acta. 2004 Dec;350(1-2):51-5. doi: 10.1016/j.cccn.2004.07.008. Clin Chim Acta. 2004. PMID: 15530459

4

Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis.

Allanore Y, Kahan A, Sellam J, Ekindjian OG, Borderie D. Allanore Y, et al. Among authors: kahan a. Clin Chim Acta. 2006 Mar;365(1-2):143-8. doi: 10.1016/j.cca.2005.08.010. Epub 2005 Sep 19. Clin Chim Acta. 2006. PMID: 16176811 Clinical Trial.

5

Inhibition of inducible NO synthase by TH2 cytokines and TGF beta in rheumatoid arthritic synoviocytes: effects on nitrosothiol production.

Borderie D, Hilliquin P, Hernvann A, Lemarechal H, Kahan A, Menkes CJ, Ekindjian OG. Borderie D, et al. Among authors: kahan a. Nitric Oxide. 2002 May;6(3):271-82. doi: 10.1006/niox.2001.0418. Nitric Oxide. 2002. PMID: 12009845

6

Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.

Allanore Y, Borderie D, Lemaréchal H, Cherruau B, Ekindjian OG, Kahan A. Allanore Y, et al. Among authors: kahan a. J Rheumatol. 2003 Jan;30(1):68-73. J Rheumatol. 2003. PMID: 12508392

7

Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.

Allanore Y, Borderie D, Lemaréchal H, Ekindjian OG, Kahan A. Allanore Y, et al. Among authors: kahan a. Arthritis Res Ther. 2004;6(4):R309-14. doi: 10.1186/ar1183. Epub 2004 May 12. Arthritis Res Ther. 2004. PMID: 15225366 Free PMC article.

8

High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis.

Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. Borderie D, et al. Among authors: kahan a. Clin Chem. 2004 Nov;50(11):2190-3. doi: 10.1373/clinchem.2004.034371. Clin Chem. 2004. PMID: 15502098 No abstract available.

9

Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.

Allanore Y, Borderie D, Périanin A, Lemaréchal H, Ekindjian OG, Kahan A. Allanore Y, et al. Among authors: kahan a. Arthritis Res Ther. 2005;7(1):R93-100. doi: 10.1186/ar1457. Epub 2004 Nov 16. Arthritis Res Ther. 2005. PMID: 15642147 Free PMC article.

10

Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study.

Meune C, Wahbi K, Assous N, Weber S, Kahan A, Allanore Y. Meune C, et al. Among authors: kahan a. J Rheumatol. 2007 Oct;34(10):2005-9. Epub 2007 Sep 1. J Rheumatol. 2007. PMID: 17787044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters